Drugs / uracil-tegafur
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00004860 | Oct 2000 → Oct 2005 | colorectal cancer | Eastern Cooperative Oncology Group | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01082510 | Jan 2010 → Dec 2017 | urinary bladder cancer | Urological Oncology Council of Northern Tokyo | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | uracil-tegafur | “PURPOSE: To evaluate the tolerability and effectiveness of uracil-tegafur (UFT) with leucovorin (LV) in the treatment of elderly patients with advanced colorectal cancer.” PMID 18048821 ↗ Dec 2007 |
| Known as | UFT | “PURPOSE: To evaluate the tolerability and effectiveness of uracil-tegafur (UFT) with leucovorin (LV) in the treatment of elderly patients with advanced colorectal cancer.” PMID 18048821 ↗ Dec 2007 |
| Route | Oral | “UFT 100 mg/m2 plus LV 30 mg orally every 8 hours for 28 days every 35 days was administered until progression.” PMID 18048821 ↗ Dec 2007 |